Three Recent Biotechnology Activist Wins by Carl Icahn
August 30, 2009 by mdbeckerpartners · Leave a Comment
Although a controversial topic, activist hedge funds and private equity firms typically use a small equity stake in an underperforming company to put public pressure on its management and board of directors with the goal of increasing stakeholder value through cost cutting, changes in corporate strategy or management, capital restructuring, asset divestiture and other tactics. [...]
Much Ado About Medarex
June 24, 2009 by mdbeckerpartners · Leave a Comment
According to their website, Discovery’s Edge is the Mayo Clinic’s online research magazine that is designed to communicate the story of scientists and researchers who are bringing treatments and improved care to patients and also reports on “works–in–progress.” Through this publication, Mayo investigators studying immunotherapy for aggressive prostate cancer reported over the past weekend that [...]
